Loading organizations...
NDI Healthcare Fund operates as a venture capital and commercialization firm, focused on innovative neurodevice technologies. It invests in and develops opportunities across the neurodevice market, encompassing stimulators, leads, surgical equipment, and software. The fund employs a hybrid model, integrating venture capital with commercialization support, efficiently moving novel neurodevice products from innovation to market.
NDI (Neuro Device Innovations), the parent firm, was established in 2002, recognizing global demand and unmet clinical needs in neurological disorders. Founder and CEO Geoff Thrope led NDI’s evolution from an incubator to a comprehensive venture model, forming the NDI Healthcare Fund. This enabled investment and commercialization of promising neurodevice innovations.
The NDI Healthcare Fund supports seed-stage companies developing neurodevices for age-related and treatment-resistant neurological conditions like Parkinson’s disease and chronic pain. Its vision capitalizes on projected growth in the neurodevice sector, advancing solutions for critical disorders. The fund aims to bring transformative neurotechnologies to a market where drug therapies are often insufficient, improving patient outcomes.
NDI Healthcare Fund has 4 tracked investments across 2 companies. The latest tracked deal is $7.5M Other Equity in Checkpoint Surgical in December 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 17, 2015 | Checkpoint Surgical | $7.5M Other Equity | — | Novel |
| Jan 8, 2013 | SPR Therapeutics | $5.0M Series A | — | Public Square Partners |
| Jan 28, 2012 | Checkpoint Surgical | $3.0M Debt / Grant / Series B | NDI Healthcare Fund | Innovation Ohio |
| Jan 24, 2012 | SPR Therapeutics | $2.2M Series A | NDI Healthcare Fund | — |
